As researchers continue to search for the cure for cancer, it continues to impact families across the nation. Officials believe that it may soon surpass heart disease as the leading cause of death in the U.S. According to The New York Times, one of the most alarming culprits of this…
Product Liability Lawyer Blog
Biomet Looks Ahead as Defective Hip Cases Move Forward
Biomet recently announced its financial results for the second quarter, indicating an increase in consolidated net sales and announcing the commercial launch of the company’s G7™ Acetabular System in 2014. The financial release indicated that the report contained forward looking statements and that the company’s actual results could be affected…
Leukemia Drug Iclusig Expected to Resume Marketing Amid Safety Concerns
A new leukemia drug hit the market last year – and approval was promptly suspended by the U.S. Food and Drug Administration amid concerns that it caused the potential for life-threatening blood clots and a severe restriction of the blood vessels. The drug, known as Iclusig and ponatinib, has reportedly…
Acetaminophen Dangers Highlighted in Recent Reports
Acetaminophen is far and away considered one of the safest drugs on the market. It’s the active ingredient in Tylenol, and tens of millions of people take this popular pain reliever and fever reducer every week with no major problems. But did you know that over the last 10 years,…
Faulty Hip Replacements Result in $56 Million Settlement from Biomet
Biomet Inc., a medical device manufacturer based in the U.S., has agreed to pay a minimum of $56 million in order to settle a multi-district lawsuit stemming from defective metal hip replacements. Court filings in the case of In Re: Biomet M2A Magnum Hip Implant Products Liability Litigation, from the…
Report: FDA-Approval Doesn’t Guarantee Drug Safety
While the U.S. Food and Drug Administration offers its stamp of approval on a wide range of medications and treatments each year, that green light is no guarantee that a drug won’t be harmful. A recent annual report by the Institute for Safe Medication Practices revealed that there was a…
FDA Requests Reports on Defective Tobacco Products
Officials with the Food and Drug Administration (FDA) recently unveiled a new online tool to let consumers report problems with any tobacco products. The Safety Reporting Portal (SRP) has been updated and now contains a new category for tobacco products. Under the update, health care professionals and consumers are provided…
Boston Attorney Jeffrey S. Glassman Joins Transvaginal Mesh MDL
Transvaginal mesh products were marketed to women seeking treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Many women who had these products implanted have experienced serious complications, resulting in significant pain and necessitating revision surgeries. Thousands of women filed lawsuits resulting from the complications, and the cases…
Boston Injury Lawyers Join Wright MDL
Wright Medical is the manufacturer of metal-on-metal hip implant products. Patients have experienced serious complications after having the Wright medical products implanted and a multidistrict litigation (MDL) has been created to expedite the handling of pending cases. Our Boston defective hip implant lawyers have been admitted to the MDL against…
Glassman Law Firm Admitted to MDLs for Wright, Stryker, DePuy Hip Implants
Metal-on-metal hip implants have prompted numerous manufacturer recalls in recent years, including a recall of the Stryker Rejuvenate; the Stryker ABG II; the DePuy XL Acetabular; and the DePuy ASR Hip Resurfacing system. Before these devices were recalled, the metal-on-metal hip implant systems were implanted in thousands of patients, many…